JBS: skyrocketing meat prices in the US amid use of anti-obesity drugs and increasing protein consumption
The anti-obesity molecule revolution is challenging the model of the industry giants, which could lose up to USD 90 billion in the US by 2031. As a result, multinationals are trying to switch to Europe and a more protein-rich offer. And US restaurants – given the level of meat inflation – are struggling and reducing staff and portions of their dishes
